Institute Of Hematology And Blood Transfusion, Czech Republic
Clinical trials sponsored by Institute Of Hematology And Blood Transfusion, Czech Republic, explained in plain language.
-
Precision proton beam may boost transplant safety for tough blood cancers
Disease control Recruiting nowThis study tests a new way to prepare the body for a stem cell transplant in people with hard-to-treat acute myeloid leukemia (AML) or myelodysplastic syndrome (MDS). Instead of standard full-body radiation, participants receive targeted proton radiation to the bone marrow and ly…
Phase: PHASE1, PHASE2 • Sponsor: Institute of Hematology and Blood Transfusion, Czech Republic • Aim: Disease control
Last updated Jun 16, 2026 12:54 UTC
-
Engineered immune cells take on tough blood cancers in early trial
Disease control Recruiting nowThis early-phase trial tests a personalized cell therapy called CART123 for adults with certain blood cancers (like acute myeloid leukemia) that have not responded to standard treatments. Each patient's own immune cells are collected, modified to target the CD123 protein on cance…
Phase: EARLY_PHASE1 • Sponsor: Institute of Hematology and Blood Transfusion, Czech Republic • Aim: Disease control
Last updated Jun 16, 2026 12:48 UTC